Pfizer will submit data to the FDA this week.
A Food and Drug Administration committee will meet in mid-June to review data on COVID-19 vaccines for children six months through five years old, the agency
A preliminary analysis of data from the clinical trial of 1,678 children also showed that the shots were around 80 percent effective at preventing symptomatic COVID-19 infections, according to the press release, but that was based on only a small number of cases.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more: